Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells

Jung Hyun Kim, Andreas Kurtz, Bao Zhu Yuan, Fanyi Zeng, Geoff Lomax, Jeanne F. Loring, Jeremy Crook, Ji Hyeon Ju, Laura Clarke, Maneesha S. Inamdar, Martin Pera, Meri T. Firpo, Michael Sheldon, Nafees Rahman, Orla O'Shea, Patricia Pranke, Qi Zhou, Rosario Isasi, Ruttachuk Rungsiwiwut, Shin KawamataSteve Oh, Tenneille Ludwig, Toru Masui, Thomas J. Novak, Tsuneo Takahashi, Wataru Fujibuchi, Soo Kyung Koo, Glyn N. Stacey

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19–20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. Stem Cells Translational Medicine 2017;6:1956–1962.

Original languageEnglish
Pages (from-to)1956-1962
Number of pages7
JournalStem cells translational medicine
Volume6
Issue number11
DOIs
Publication statusPublished - 2017 Nov 1

Fingerprint

Pluripotent Stem Cells
Seeds
Stem Cells
Education
Cell- and Tissue-Based Therapy
Medicine
Safety
Stem Cell Research
Regenerative Medicine
Translational Medical Research
National Institutes of Health (U.S.)
Korea
Quality Control
Research

Keywords

  • Data standardization
  • Human embryonic stem cell (hESC)
  • Human pluripotent stem cells
  • Induced pluripotent stem cell (iPSC)
  • Informed consents
  • Quality assurance
  • Quality control
  • Stem cell banking

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Cite this

Report of the International Stem Cell Banking Initiative Workshop Activity : Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. / Kim, Jung Hyun; Kurtz, Andreas; Yuan, Bao Zhu; Zeng, Fanyi; Lomax, Geoff; Loring, Jeanne F.; Crook, Jeremy; Ju, Ji Hyeon; Clarke, Laura; Inamdar, Maneesha S.; Pera, Martin; Firpo, Meri T.; Sheldon, Michael; Rahman, Nafees; O'Shea, Orla; Pranke, Patricia; Zhou, Qi; Isasi, Rosario; Rungsiwiwut, Ruttachuk; Kawamata, Shin; Oh, Steve; Ludwig, Tenneille; Masui, Toru; Novak, Thomas J.; Takahashi, Tsuneo; Fujibuchi, Wataru; Koo, Soo Kyung; Stacey, Glyn N.

In: Stem cells translational medicine, Vol. 6, No. 11, 01.11.2017, p. 1956-1962.

Research output: Contribution to journalArticle

Kim, JH, Kurtz, A, Yuan, BZ, Zeng, F, Lomax, G, Loring, JF, Crook, J, Ju, JH, Clarke, L, Inamdar, MS, Pera, M, Firpo, MT, Sheldon, M, Rahman, N, O'Shea, O, Pranke, P, Zhou, Q, Isasi, R, Rungsiwiwut, R, Kawamata, S, Oh, S, Ludwig, T, Masui, T, Novak, TJ, Takahashi, T, Fujibuchi, W, Koo, SK & Stacey, GN 2017, 'Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells', Stem cells translational medicine, vol. 6, no. 11, pp. 1956-1962. https://doi.org/10.1002/sctm.17-0144
Kim, Jung Hyun ; Kurtz, Andreas ; Yuan, Bao Zhu ; Zeng, Fanyi ; Lomax, Geoff ; Loring, Jeanne F. ; Crook, Jeremy ; Ju, Ji Hyeon ; Clarke, Laura ; Inamdar, Maneesha S. ; Pera, Martin ; Firpo, Meri T. ; Sheldon, Michael ; Rahman, Nafees ; O'Shea, Orla ; Pranke, Patricia ; Zhou, Qi ; Isasi, Rosario ; Rungsiwiwut, Ruttachuk ; Kawamata, Shin ; Oh, Steve ; Ludwig, Tenneille ; Masui, Toru ; Novak, Thomas J. ; Takahashi, Tsuneo ; Fujibuchi, Wataru ; Koo, Soo Kyung ; Stacey, Glyn N. / Report of the International Stem Cell Banking Initiative Workshop Activity : Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells. In: Stem cells translational medicine. 2017 ; Vol. 6, No. 11. pp. 1956-1962.
@article{7c70148b0f79427d88be787111ed0a22,
title = "Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells",
abstract = "This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19–20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. Stem Cells Translational Medicine 2017;6:1956–1962.",
keywords = "Data standardization, Human embryonic stem cell (hESC), Human pluripotent stem cells, Induced pluripotent stem cell (iPSC), Informed consents, Quality assurance, Quality control, Stem cell banking",
author = "Kim, {Jung Hyun} and Andreas Kurtz and Yuan, {Bao Zhu} and Fanyi Zeng and Geoff Lomax and Loring, {Jeanne F.} and Jeremy Crook and Ju, {Ji Hyeon} and Laura Clarke and Inamdar, {Maneesha S.} and Martin Pera and Firpo, {Meri T.} and Michael Sheldon and Nafees Rahman and Orla O'Shea and Patricia Pranke and Qi Zhou and Rosario Isasi and Ruttachuk Rungsiwiwut and Shin Kawamata and Steve Oh and Tenneille Ludwig and Toru Masui and Novak, {Thomas J.} and Tsuneo Takahashi and Wataru Fujibuchi and Koo, {Soo Kyung} and Stacey, {Glyn N.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1002/sctm.17-0144",
language = "English",
volume = "6",
pages = "1956--1962",
journal = "Stem cells translational medicine",
issn = "2157-6564",
publisher = "AlphaMed Press",
number = "11",

}

TY - JOUR

T1 - Report of the International Stem Cell Banking Initiative Workshop Activity

T2 - Current Hurdles and Progress in Seed-Stock Banking of Human Pluripotent Stem Cells

AU - Kim, Jung Hyun

AU - Kurtz, Andreas

AU - Yuan, Bao Zhu

AU - Zeng, Fanyi

AU - Lomax, Geoff

AU - Loring, Jeanne F.

AU - Crook, Jeremy

AU - Ju, Ji Hyeon

AU - Clarke, Laura

AU - Inamdar, Maneesha S.

AU - Pera, Martin

AU - Firpo, Meri T.

AU - Sheldon, Michael

AU - Rahman, Nafees

AU - O'Shea, Orla

AU - Pranke, Patricia

AU - Zhou, Qi

AU - Isasi, Rosario

AU - Rungsiwiwut, Ruttachuk

AU - Kawamata, Shin

AU - Oh, Steve

AU - Ludwig, Tenneille

AU - Masui, Toru

AU - Novak, Thomas J.

AU - Takahashi, Tsuneo

AU - Fujibuchi, Wataru

AU - Koo, Soo Kyung

AU - Stacey, Glyn N.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19–20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. Stem Cells Translational Medicine 2017;6:1956–1962.

AB - This article summarizes the recent activity of the International Stem Cell Banking Initiative (ISCBI) held at the California Institute for Regenerative Medicine (CIRM) in California (June 26, 2016) and the Korean National Institutes for Health in Korea (October 19–20, 2016). Through the workshops, ISCBI is endeavoring to support a new paradigm for human medicine using pluripotent stem cells (hPSC) for cell therapies. Priority considerations for ISCBI include ensuring the safety and efficacy of a final cell therapy product and quality assured source materials, such as stem cells and primary donor cells. To these ends, ISCBI aims to promote global harmonization on quality and safety control of stem cells for research and the development of starting materials for cell therapies, with regular workshops involving hPSC banking centers, biologists, and regulatory bodies. Here, we provide a brief overview of two such recent activities, with summaries of key issues raised. Stem Cells Translational Medicine 2017;6:1956–1962.

KW - Data standardization

KW - Human embryonic stem cell (hESC)

KW - Human pluripotent stem cells

KW - Induced pluripotent stem cell (iPSC)

KW - Informed consents

KW - Quality assurance

KW - Quality control

KW - Stem cell banking

UR - http://www.scopus.com/inward/record.url?scp=85032507617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032507617&partnerID=8YFLogxK

U2 - 10.1002/sctm.17-0144

DO - 10.1002/sctm.17-0144

M3 - Article

C2 - 29067781

AN - SCOPUS:85032507617

VL - 6

SP - 1956

EP - 1962

JO - Stem cells translational medicine

JF - Stem cells translational medicine

SN - 2157-6564

IS - 11

ER -